These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
606 related items for PubMed ID: 22230363
1. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Breast Cancer Res; 2012 Jan 09; 14(1):R10. PubMed ID: 22230363 [Abstract] [Full Text] [Related]
2. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P. Lancet Oncol; 2013 Jun 09; 14(7):583-9. PubMed ID: 23623721 [Abstract] [Full Text] [Related]
5. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J. Lancet Oncol; 2016 Jan 09; 17(1):109-14. PubMed ID: 26655422 [Abstract] [Full Text] [Related]
7. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA, Breast Cancer Surveillance Consortium. JAMA Oncol; 2015 Nov 09; 1(8):1069-77. PubMed ID: 26501844 [Abstract] [Full Text] [Related]
8. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening. Weigel S, Batzler WU, Decker T, Hense HW, Heindel W. Rofo; 2009 Dec 09; 181(12):1144-50. PubMed ID: 19859859 [Abstract] [Full Text] [Related]
9. Trends in surgery for screen-detected and interval breast cancers in a national screening programme. Nederend J, Duijm LE, Louwman MW, Roumen RM, Jansen FH, Voogd AC. Br J Surg; 2014 Jul 09; 101(8):949-58. PubMed ID: 24828281 [Abstract] [Full Text] [Related]
11. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Glass AG, Lacey JV, Carreon JD, Hoover RN. J Natl Cancer Inst; 2007 Aug 01; 99(15):1152-61. PubMed ID: 17652280 [Abstract] [Full Text] [Related]
12. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Hofvind S, Holen ÅS, Aase HS, Houssami N, Sebuødegård S, Moger TA, Haldorsen IS, Akslen LA. Lancet Oncol; 2019 Jun 01; 20(6):795-805. PubMed ID: 31078459 [Abstract] [Full Text] [Related]
14. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases. Újhelyi M, Pukancsik D, Kelemen P, Kovács E, Kenessey I, Udvarhelyi N, Bak M, Kovács T, Mátrai Z. Eur J Surg Oncol; 2016 Dec 01; 42(12):1814-1820. PubMed ID: 27424787 [Abstract] [Full Text] [Related]
16. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Hofvind S, Lee CI, Elmore JG. Breast Cancer Res Treat; 2012 Aug 01; 135(1):291-9. PubMed ID: 22833199 [Abstract] [Full Text] [Related]
20. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Gangnon RE, Sprague BL, Stout NK, Alagoz O, Weedon-Fekjær H, Holford TR, Trentham-Dietz A. Cancer Epidemiol Biomarkers Prev; 2015 Jun 01; 24(6):905-12. PubMed ID: 25787716 [Abstract] [Full Text] [Related] Page: [Next] [New Search]